title: Approach and management of patients with chronic hepatitis B and C during the course of inflammatory bowel disease.
abstract: Inflammatory bowel disease and chronic viral hepatitis are 2 distinct but common conditions throughout the world. Mostly, both need life-long follow-up. Since immunosuppressive drugs remain corner stones of inflammatory bowel disease management, one should be aware of the concomitant presence of chronic viral hepatitis in such patients to prevent serious (even fatal) outcomes. Recently, new treatment options have become available in the treatment of both inflammatory bowel disease and chronic viral hepatitis. In this review, we have discussed and summarized current treatment and follow-up strategies for those 2 important public health issues in light of available literature.
authors: *Department of Gastroenterology, Diskapi Research and Training Hospital, Ankara, Turkey; †Department of Gastroenterology, Ankara Research and Training Hospital, Ankara, Turkey; and ‡Department of Gastroenterology, Hacettepe University School of Medicine, Ankara, Turkey.
authors: Sahin
authors: S
authors: Coban
authors: Murat
authors: M
authors: Kekilli
authors: Seyfettin
authors: S
authors: Köklü
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D019468:Disease Management; D016174:Hepacivirus / Q000302:isolation & purification; D006515:Hepatitis B virus / Q000302:isolation & purification; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000209:etiology; D006526:Hepatitis C / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000821:virology*; D011379:Prognosis; D012307:Risk Factors
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents